Verseon Highlighted in Nano Magazine Feature on AI in Drug Discovery

Verseon recently received coverage in Nano Magazine. The article discusses the company's holistic approach to drug discovery that includes not only AI but also fundamental advances across many different scientific fields. It also cites the company's 14 novel drug candidates as evidence Verseon's platform works. Article content follows: